远端小曲管mTORc2在高钾摄入时调节肾脏排钾
本研究探讨远端小曲管(DCT)中mTORc2对基底侧Kir4.1/Kir5.1、NCC及肾脏排钾的调节作用。采用膜片钳、免疫印迹和免疫荧光及小鼠模型,发现抑制mTORc2或敲除DCT-RICTOR可增加Kir4.1/Kir5.1活性、上调pNCC、降低排钾并导致高钾血症。
要点
- 高钾摄入刺激DCT中mTORc2活性。
- 抑制DCT mTORc2降低肾脏排钾能力。
- DCT-RICTOR敲除小鼠出现高钾血症。
核心结论
- DCT的mTORc2抑制Kir4.1/Kir5.1活性和NCC表达,并在高钾摄入时刺激肾脏排钾。
研究设计与样本
- 研究使用膜片钳技术检测早期DCT基底侧Kir4.1/Kir5.1,免疫印迹和免疫荧光检测NCC表达,并在mTORc2抑制剂处理小鼠和DCT特异性RICTOR敲除小鼠中体内测量尿钾排泄。
主要发现
- AZD8055抑制mTORc2消除高钾诱导的Kir4.1/Kir5.1抑制、DCT膜去极化及pNCC表达抑制。
- AZD8055处理小鼠过夜高钾饮食下肾脏排钾降低。
- DCT-RICTOR-KO小鼠Kir4.1/Kir5.1介导的钾电流增加、DCT膜超极化、pWNK4和pNCC表达增加。
- DCT-RICTOR-KO小鼠肾脏排钾低于对照、血浆钾高于对照。
- 过夜高钾饮食在DCT-RICTOR-KO小鼠中未抑制Kir4.1/Kir5.1活性和pNCC表达,排钾增加效应减弱并出现高钾血症。
关键数值与推荐
- 使用mTORc2抑制剂AZD8055处理小鼠。
- DCT特异性敲除RICTOR(DCT-RICTOR-KO)小鼠。
- 过夜高钾饮食刺激肾脏排钾。
临床怎么用
- DCT mTORc2可能成为调节钾排泄的潜在靶点,但需进一步临床验证。
局限性
- 研究仅在小鼠中进行,人体结果未知。
- 未报告具体样本量、P值等统计细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: High K stimulates mechanistic target of rapamycin complex 2 (mTORc2) in the distal convoluted tubule (DCT). Inhibition of mTORc2 decreased the basolateral Kir4.1/Kir5.1 and Na-Cl cotransporter in the DCT. Inhibition of mTORc2 of the DCT compromised kidneys' ability to excrete potassium during high K intake. BACKGROUND: Renal mechanistic target of rapamycin complex 2 (mTORc2) plays a role in regulating renal K+ excretion (renal-EK) and K+ homeostasis. Inhibition of renal mTORc2 causes hyperkalemia due to suppressing epithelial Na+ channel and renal outer medullary K+ (Kir1.1) in the collecting duct. We now explore whether mTORc2 of distal convoluted tubules (DCTs) regulates basolateral Kir4.1/Kir5.1, Na-Cl cotransporter (NCC), and renal-EK. METHODS: We used patch-clamp technique to examine basolateral Kir4.1/Kir5.1 in early DCT, immunoblotting, and immunofluorescence to examine NCC expression and in vivo measurement of urinary K+ excretion to determine baseline renal-EK in mice treated with an mTORc2 inhibitor and in DCT-specific rapamycin-insensitive companion of mTOR knockout (DCT-RICTOR-KO) mice. RESULTS: Inhibition of mTORc2 with AZD8055 abolished high-K+–induced inhibition of Kir4.1/Kir5.1 in DCT, high potassium–induced depolarization of the DCT membrane, and high potassium–induced suppression of phosphorylated Na-Cl cotransporter (pNCC) expression. AZD8055 stimulated the 40-pS inwardly rectifying K+ channel (Kir4.1/Kir5.1-heterotetramer) in early DCT in the mice on overnight high potassium intake; this effect was absent in the presence of protein kinase C inhibitors, which also stimulated Kir4.1/Kir5.1. AZD8055 treatment decreased renal-EK in animals on overnight high-potassium diet. Deletion of RICTOR in the DCT increased the Kir4.1/Kir5.1-mediated K+ currents, hyperpolarized the DCT membrane, and increased the expression of pWNK4 and pNCC. Renal-EK was lower and plasma K+ was higher in DCT-RICTOR-KO mice than corresponding control mice. In addition, overnight high-potassium diet did not inhibit Kir4.1/Kir5.1 activity in the DCT and failed to inhibit the expression of pNCC in DCT-RICTOR-KO mice. Overnight high potassium intake stimulated renal-EK in control mice, but this effect was attenuated in DCT-RICTOR-KO mice. Thus, overnight high potassium intake induced hyperkalemia in DCT-RICTOR-KO mice but not in control mice. CONCLUSIONS: mTORc2 of the DCT inhibits Kir4.1/Kir5.1 activity and NCC expression and stimulates renal-EK during high potassium intake.
引用
- Duan XP, Zheng JY, Jiang SP, et al. mTORc2 in Distal Convoluted Tubule and Renal K + Excretion during High Dietary K + Intake. J Am Soc Nephrol. 2024. PMID: 38788191. doi:10.1681/ASN.0000000000000406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。